APRIL BECK: Open Payments
NPI 1215596606 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 43 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $142 |
| Novo Nordisk Inc | 7 | $128 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| PFIZER INC. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 6 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
Products named: CAPLYTA, Ozempic, Rybelsus, VOQUEZNA, FARXIGA, BREZTRI, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across GA — which companies pay providers there.
